Affiliation:
1. Laboratoire SIMPA, Département d’Informatique, Université des Sciences et de la Technologie d’Oran Mohamed Boudiaf (USTO-MB), Oran 31000, Algeria
2. Centre de Recherche en Informatique de Lens, CRIL, CNRS, Université d’Artois, 62307 Lens, France
Abstract
Hospitals generate a significant amount of medical data every day, which constitute a very rich database for research. Today, this database is still not exploitable because to make its valorization possible, the images require an annotation which remains a costly and difficult task. Thus, the use of an unsupervised segmentation method could facilitate the process. In this article, we propose two approaches for the semantic segmentation of breast cancer histopathology images. On the one hand, an autoencoder architecture for unsupervised segmentation is proposed, and on the other hand, an improvement U-Net architecture for supervised segmentation is proposed. We evaluate these models on a public dataset of histological images of breast cancer. In addition, the performance of our segmentation methods is measured using several evaluation metrics such as accuracy, recall, precision and F1 score. The results are competitive with those of other modern methods.
Subject
Electrical and Electronic Engineering,Biochemistry,Instrumentation,Atomic and Molecular Physics, and Optics,Analytical Chemistry
Reference53 articles.
1. A review and comparison of breast tumor cell nuclei segmentation performances using deep convolutional neural networks;Lagree;Sci. Rep.,2021
2. Diagnosis of breast lesions using the local Chan-Vese model, hierarchical fuzzy partitioning and fuzzy decision tree induction;Boutaouche;Iran. J. Fuzzy Syst.,2017
3. Mammographic images interpretation using Neural-Evolutionary approach;Belgrana;Int. J. Comput. Sci.,2012
4. Boundary-rendering Network for Breast Lesion Segmentation in Ultrasound Images;Huang;Med. Image Anal.,2022
5. Convolutional neural network of multiparametric MRI accurately detects axillary lymph node metastasis in breast cancer patients with PR neoadjuvant chemotherapy;Ren;Clin. Breast Cancer,2022